CERo Therapeutics, Inc. Alternatives & Competitors
12 companies similar to CERo Therapeutics, Inc. — Tumor Cell Clearance Reimagined.
Companies similar to CERo Therapeutics, Inc.
Poseida Therapeutics, Inc.
A Member of the Roche Group
San Diego, United States
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
TScan Therapeutics
Unleash Immunity
Waltham, United States
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Rival Readout
Competing with CERo Therapeutics, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
2seventy bio
It’s about time we think smarter and faster than cancer.
Cambridge, United States
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
Neobe Therapeutics
Engineering live biotherapeutics to disrupt the tumour microenvironment and enable immunot...
London, United Kingdom
Auron Therapeutics, Inc.
Targeting cell state to deliver next-generation targeted cancer therapies
Newton, United States
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
Aurora, United States
Refuge Biotechnologies
DESIGNING INTELLIGENT CELL THERAPIES TO FIGHT CANCER
Menlo Park, United States
About CERo Therapeutics, Inc.
CERo Therapeutics, Inc., founded in 2017, is a promising player in the Biotechnology and Health and Wellness sectors. Headquartered in the United States, this innovative company is reimagining tumor cell clearance under its slogan, "Tumor Cell Clearance Reimagined." The company is leveraging its expertise in cellular c...
Development of curative cell therapies, Customization of T-cell platforms, Integration of immune system capabilities
Healthcare Providers, Research Institutions, Oncologists, Biotechnology Investors, Pharmaceutical Companies
Cellular Immunotherapy, Adoptive Cell Therapy, Immuno Oncology, Synthetic Biology, Gene Engineering, Flow Cytometry, Immunology, Tumor Immunology, Solid Tumors, Molecular Immunology, Molecular Biology, Hematopoietic Cell Transplantation
B2B, B2B2C
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around CERo Therapeutics, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at CERo Therapeutics, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
